<HashMap><database>biostudies-arrayexpress</database><scores/><additional><submitter>Adam Yongxin Ye</submitter><organism>Mus musculus</organism><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-16014</full_dataset_link><description>We performed Gro-seq in v-Abl transformed pro-B cells and its various mutant derivatives to study the differential molecular mechanisms of Igk secondary V(D)J recombination.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Sequencing - GRO-seq libraries were prepared from the G1-arrested, RAG2-deficient v-Abl cell lines as described, sequenced using Illumina NextSeq2000 using paired-end 150-bp sequencing kits, and processed with a previously described pipeline.</sample_protocol><sample_protocol>Sample Treatment - G1-arrest was performed by treating v-Abl cell lines with 3uM STI for 4 days</sample_protocol><sample_protocol>Library Construction - Illumina adapters were ligated to RNA followed by cDNA generation with reverse transcriptase.  Libraries were PCR-amplified with Illumina primers and subjected to sequencing.</sample_protocol><sample_protocol>Growth Protocol - v-Abl cell lines were cultured in RPMI1640 media with 15% FBS</sample_protocol><sample_protocol>Sample Collection - Briefly, 10 million cells were permeabilized with permeabilization buffer (10 mM Tris-HCl, pH 7.4, 300 mM sucrose, 10 mM KCl, 5 mM MgCl2, 1 mM EGTA, 0.05% Tween-20, 0.1% NP40 substitute, 0.5 mM DTT, one tablet of protease inhibitors per 50 ml and 4 units Rnase inhibitor per ml) and resuspended in 100 ul storage buffer (10 mM Tris-HCl, pHHH 8.0, 25% (vol/vol) glycerol, 5 mM MgCl2, 0.1 mM EDTA and 5 mM DTT). Permeabilized cells were subjected to nuclear run-on (2xRun-on mix: 5 mM Tris-Cl, PH 8.0, 2.5 mM MgCl2, 0.5 mM DTT, 150 mM KCl, 0.5 mM ATP, 0.5 mM CTP, 0.5 mM GTP, 0.5 mM BrUTP, 10 units of RNase inhibitor, 1% sarkosyl) at 37o for 5 min, followed by Trizol-based RNA extraction.</sample_protocol><sample_protocol>Nucleic Acid Extraction - Briefly, 10 million cells were permeabilized with permeabilization buffer (10 mM Tris-HCl, pH 7.4, 300 mM sucrose, 10 mM KCl, 5 mM MgCl2, 1 mM EGTA, 0.05% Tween-20, 0.1% NP40 substitute, 0.5 mM DTT, one tablet of protease inhibitors per 50 ml and 4 units Rnase inhibitor per ml) and resuspended in 100 ul storage buffer (10 mM Tris-HCl, pHHH 8.0, 25% (vol/vol) glycerol, 5 mM MgCl2, 0.1 mM EDTA and 5 mM DTT). Permeabilized cells were subjected to nuclear run-on (2xRun-on mix: 5 mM Tris-Cl, PH 8.0, 2.5 mM MgCl2, 0.5 mM DTT, 150 mM KCl, 0.5 mM ATP, 0.5 mM CTP, 0.5 mM GTP, 0.5 mM BrUTP, 10 units of RNase inhibitor, 1% sarkosyl) at 37o for 5 min, followed by Trizol-based RNA extraction.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>Processed Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><data_protocol>Sequence Alignment - Reads were aligned to AJ851868/mm9 hybrid genome using bowtie 2.2.8 with --non-deterministic flag</data_protocol><data_protocol>Data Transformation - All GRO-seq libraries were downsampled normalized to the smallest read number among the GRO-seq libraries</data_protocol><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><instrument_platform>NextSeq 2000</instrument_platform><study_type>GRO-seq</study_type><species>Mus musculus</species><pubmed_authors>Adam Yongxin Ye</pubmed_authors><pubmed_authors>Frederick Alt</pubmed_authors></additional><is_claimable>false</is_claimable><name>GRO-seq for Linear RAG Scanning Mediates Editing of Igκ Variable Region Repertoires</name><description>We performed Gro-seq in v-Abl transformed pro-B cells and its various mutant derivatives to study the differential molecular mechanisms of Igk secondary V(D)J recombination.</description><dates><release>2026-02-23T00:00:00Z</release><modification>2026-05-27T12:28:51.214Z</modification><creation>2025-11-13T14:53:31.243Z</creation></dates><accession>E-MTAB-16014</accession><cross_references><ENA>ERP183878</ENA><Biostudies>E-MTAB-16001</Biostudies><Biostudies>E-MTAB-16007</Biostudies><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0003789</EFO><EFO>EFO_0005227</EFO><EFO>EFO_0004917</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003816</EFO><EFO>EFO_0004184</EFO><EFO>EFO_0003969</EFO></cross_references></HashMap>